Codexis Becomes Target for Suitor Seeking Enzymes, CEO Says

Codexis Inc., the U.S. enzyme maker that has worked with Royal DSM NV and Royal Dutch Shell Plc, said it’s a potential takeover target as chemical companies expand in higher-margin markets such as biofuels from plants.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.